|
|
基于网络药理学探讨玉蝴蝶祛斑膏治疗黄褐斑的作用机制
|
Abstract:
目的：采用网络药理学的分析方法，探讨玉蝴蝶祛斑膏治疗黄褐斑疾病的作用机制。方法：通过TCMSP数据库收集玉蝴蝶祛斑膏潜在有效活性化合物，并通过Swiss Target Prediction数据库筛查其潜在有效活性化合物的人类潜在有效靶点蛋白；在DisGeNET、GeneCards、TTD等数据库筛查黄褐斑的疾病靶点蛋白；通过STRING数据库构建蛋白–蛋白互作网络数据，并利用Cytoscape软件进行可视化拓扑结构分析，将关键靶点蛋白通过DAVID数据库进行基因功能和通路富集分析。结果：筛选得到玉蝴蝶祛斑膏中潜在有效活性成分66个，所对应潜在靶点蛋白478个，与黄褐斑疾病相关疾病靶点蛋白120个。“成分–靶点”网络图提示槲皮素、黄芩素等是玉蝴蝶祛斑膏治疗黄褐斑疾病的关键成分。GO富集分析结果显示，共有225个条目与生物过程相关，共有40个条目与细胞组成相关，共有63个条目与分子功能相关；富集分析显示，参与治疗黄褐斑疾病的关键靶点蛋白主要与131条通路相关联，其主要涉及癌症通路、癌症蛋白聚糖通路等。其中癌症通路的P值最高。结论：文章利用网络药理学多成分、多靶点、多维度、多途径的分析方法，较为全面地阐明了玉蝴蝶祛斑膏治疗黄褐斑疾病的作用特点，初步揭示了玉蝴蝶祛斑膏治疗黄褐斑疾病的有效基础物质和作用机制，为后续研究提供思路与依据。
Objective: To investigate the mechanism of Yuhudie Macula-removing in the treatment of chloasma by means of network pharmacological analysis. Methods: The potential active compounds of Yuhudie Macula-removing were collected by TCMSP database, and its human potential effective target protein of the potential active compounds was screened by Swiss Target Prediction database. The target proteins of chloasma were screened in DisGeNET, GeneCards, TTD and other databases. The protein-protein interaction network data was constructed by using STRING database, and the visual topological structure analysis was carried out by using Cytoscape software. The gene function and pathway enrichment of key target proteins were analyzed through the DAVID database. Results: 66 potential active ingredients, 478 potential target proteins and 120 target proteins related to chloasma disease were selected. The “component-target” network diagram indicates that quercetin and baicalein are the key components of Yuhudie Macula-removing in the treatment of chloasma disease. GO enrichment analysis showed that 225 items were related to biological processes, 40 items were related to cell composition, and 63 items were related to molecular function. Enrichment analysis showed that the key target proteins involved in the treatment of chloasma disease were mainly associated with 131 pathways, which mainly involved cancer pathways and cancer proteoglycan pathways. The cancer pathway has the highest P value. Conclusion: Using the multi-component, multi-target, multi-dimensional, multi-pathway analysis method of network pharmacology, this paper comprehensively elucidates the action characteristics of Yuhudie Macula-removing in the treatment of chloasma disease, and initially reveals the effective basic substances and mechanism of action of Yuhudie Macula-removing in the treatment of chloasma disease, providing ideas and basis for subsequent research.
| [1] | Cario, M. (2019) How Hormones May Modulate Human Skin Pigmentation in Melasma: An in Vitro Perspective. Experimental Dermatology, 28, 709-718. https://doi.org/10.1111/exd.13915 |
| [2] | Tamega, A., Miot, H.A., Mo？o, N.P., et al. (2015) Gene and Protein Expression of Oestrogen-β and Progesterone Receptors in Facial Melasma and Ad-jacent Healthy Skin in Women. International Journal of Cosmetic Science, 37, 222-228. |
| [3] | Sarkar, R., Ailawadi, P., Garg, S., et al. (2018) A Review of Clinical, Etiological, and Management Issues. The Journal of Clinical and Aesthetic Dermatology, 11, 53-59. |
| [4] | Jang, Y.H., Lee, J.Y., Kang, H.Y., et al. (2010) Oestrogen and Progesterone Receptor Expression in Melasma: An Immunohistochemical Analysis. Journal of the European Academy of Dermatology and Ve-nereology: JEADV, 24, 1312-1316. https://doi.org/10.1111/j.1468-3083.2010.03638.x |
| [5] | Hernández, B.R., Torres, A.B., Castanedo, C.J.P., et al. (2008) Solar Elastosis and Presence of Mast Cells as Key Features in the Patho-genesis of Melasma. Clinical and Experimental Dermatology, 33, 305-308.
https://doi.org/10.1111/j.1365-2230.2008.02724.x |
| [6] | Passeron, T. and Picardo, M. (2017) Melasma, a Photoag-ing Disorder. Pigment Cell & Melanoma Research, 31, 461-465.
https://doi.org/10.1111/pcmr.12684 |
| [7] | Soon, H.K., Young, J.H., Soo, K.L., et al. (2016) Heterogeneous Pathol-ogy of Melasma and Its Clinical Implications. International Journal of Molecular Sciences, 17, Article 824. https://doi.org/10.3390/ijms17060824 |
| [8] | Abdel, N.M., Seltmann, H. and Zouboulis, C. (2012) SZ95 Sebocytes Induce Epidermal Melanocyte Dendricity and Proliferation in Vitro. Experimental Dermatology, 21, 393-395. https://doi.org/10.1111/j.1600-0625.2012.01468.x |
| [9] | Inomata, S., Matsunaga, Y., Amano, S., et al. (2003) Pos-sible Involvement of Gelatinases in Basement Membrane Damage and Wrinkle Formation in Chronically Ultraviolet B-Exposed Hairless Mouse. The Journal of Investigative Dermatology, 120, 128-134. https://doi.org/10.1046/j.1523-1747.2003.12021.x |
| [10] | 胡月珍, 易继才, 彭晓国, 等. 玉蝴蝶美容祛斑膏及其制备方法[P]. 中国专利, CN101342223B. 2013-02-20. |
| [11] | Hopkins, A.L. (2007) Network Pharmacology. Nature Biotechnology, 25, 1271-1273.
https://doi.org/10.1038/nbt1007-1110 |
| [12] | 胡栋宝, 赵剑雄. 中药满山红中4个黄酮类化合物结构及其抗氧化活性的理论研究[J]. 中国中药杂志, 2016, 41(14): 2675-2679. |
| [13] | 李菁萱, 梁继展, 练秀媚, 等. 橘红中黄酮成分的提取工艺及其抗氧化活性研究[J]. 山西化工, 2023, 43(4): 9-10+32. https://doi.org/10.16525/j.cnki.cn14-1109/tq.2023.04.003 |
| [14] | 刘艺苑, 刘传敏, 李新朋, 等. 金莲花黄酮类成分抗菌及抗氧化活性研究[J]. 药学研究, 2023, 42(4): 228-231+242. https://doi.org/10.13506/j.cnki.jpr.2023.04.003 |
| [15] | 荣家闵, 张仁文. 槲皮素体外抗氧化活性研究[J]. 科学技术创新, 2019(29): 43-44. |
| [16] | 耿佳琳, 焦玉苗, 焉炳飞, 等. 罗布麻中5种黄酮化合物抗氧化活性DFT研究[J]. 当代化工, 2015, 44(12): 2763-2765. https://doi.org/10.13840/j.cnki.cn21-1457/tq.2015.12.011 |
| [17] | 张倩, 李惠香, 刘攀, 等. 黄芩素的体外抗炎及抗氧化活性研究[J]. 烟台大学学报(自然科学与工程版), 2018, 31(3): 232-238. https://doi.org/10.13951/j.cnki.37-1213/n.2018.03.008 |
| [18] | 黄明春, 陈剑鸿, 胡小刚, 等. 金丝桃苷对CCl4诱导大鼠急性肝损伤抗氧化应激研究[J]. 局解手术学杂志, 2013, 22(6): 588-590+593. |
| [19] | 潘素跃, 胡敏, 王朴, 等. 逍遥丸治疗黄褐斑的分子机制: 基于整合网络药理学和生物信息学方法[J]. 皮肤性病诊疗学杂志, 2023, 30(3): 211-218. |
| [20] | 曹站霞, 陈毓龙, 李伟霞, 等. 基于网络药理学和细胞试验探讨补骨脂致肝损伤的毒理机制[J]. 中国现代应用药学, 2022, 39(16): 2052-2062. https://doi.org/10.13748/j.cnki.issn1007-7693.2022.16.002 |
| [21] | 赵静, 袁瑞华, 王海芳, 等. 活血胶囊激活PI3K/Akt/Nrf2/HO-1通路对血管内皮细胞发挥抗氧化损伤作用[J]. 云南中医学院学报, 2019, 42(3): 10-16. https://doi.org/10.19288/j.cnki.issn.1000-2723.2019.03.002 |
